menu search

Elliott wave update of usdcad – november 1st, 2023

USDCAD is more or less unchanged since the start of the week as traders await the Fed's decision on interest rates later today. Is Jay Powell going to...

November 1, 2023, 7:54 am

Aptevo to present at bio-europe conference

SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biot...

November 1, 2023, 7:45 am

Celcuity to present at upcoming stifel and jefferies investor conferences

MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechno...

November 1, 2023, 7:05 am

Astrazeneca inks gene editing deal that could end up costing it $2.5bn

AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist b...

November 1, 2023, 3:59 am

Astrazeneca signs drug development deal with biotech cellectis

AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical-stage b...

November 1, 2023, 3:17 am

Unlocking value in bitcoin mining – analyst selects riot and clsk as top picks

Bernstein analyst Gautam Chhugani initiated coverage on U.S. Bitcoin miners with an Outperform rating on Riot<...

October 31, 2023, 6:59 pm

Pfizer to sees no major m&a activity in 2024: ceo bourla

Pfizer Chairman and CEO Albert Bourla says the company is still in the market for acquisitions following its $43 billion acquisition of cancer b...

October 31, 2023, 3:30 pm

Blackberry ceo transition comes as tech firm prepares to split off iot business

Blackberry (TSX:BB)'s longtime CEO John Chen is retiring from his role at a pivotal moment for the firm as it intends to split its Internet of Things ...

October 31, 2023, 3:03 pm

Crsp stock halt: crispr trading halted ahead of fda decision

Among the more prominent gene-editing stocks on the market, investors in this space pay particularly close attention to CRISPR Therapeutics (NASDAQ: C...

October 31, 2023, 2:11 pm

Amicus therapeutics: the right play now

Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rar...

October 31, 2023, 12:24 pm

Innovation could propel biotechnology bounce

Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a ...

October 31, 2023, 11:28 am

Nautilus biotechnology, inc. (naut) q3 2023 earnings call transcript

Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2023 Earnings Conference Call October 31, 2023 8:30 AM E...

October 31, 2023, 11:22 am

Arcutis biotherapeutics, inc. (arqt) loses -51.27% in 4 weeks, here's why a trend reversal may be around the corner

The heavy selling pressure might have exhausted for Arcutis Biotherapeutics, Inc. (ARQT) as it is techn...

October 31, 2023, 11:21 am

Spyglass pharma initiates phase i/ii clinical trial of its intraocular drug delivery platform

Phase I/II trial initiated to investigate innovative SpyGlass platform for the long-term delivery of bimatoprost in patients with glaucoma and visuall...

October 31, 2023, 11:00 am

Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3

Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) — Verve Thera...

October 31, 2023, 10:01 am

Xilio to host virtual investor conference call and webcast on monday, november 6, 2023 to review progress across pipeline, including phase 1/2 clinical data for xtx202, a tumor-activated, engineered,

WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage bio...

October 31, 2023, 9:15 am

Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting

SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a b...

October 31, 2023, 9:05 am

Amgen stock unmoved by earnings beat

In contrast to market expectations, shares of Amgen, Inc. (NASDAQ:AMGN) remained flat even as the biot...

October 31, 2023, 8:46 am

iot device management market size worth usd 10.42 billion in 2031, registering at a cagr of 18.7% says, transparency market research inc

The risk of exposing confidential information and data is a critical challenge. With the increasing number of ...

October 31, 2023, 8:30 am

Is invesco biotechnology & genome etf (pbe) a strong etf right now?

A smart beta exchange traded fund, the Invesco Biotechnology & Genome ETF (PBE) debuted on 06/23/2005, ...

October 31, 2023, 7:31 am


Search within

Pages Search Results: